Beclazone Easi-Breathe to be phased out

Teva has confirmed that they will cease supply of all strengths of Beclazone Easi-Breathe (beclometasone diproprionate) inhalers from 30 September 2009. The inhalers are being discontinued in line with the Montreal Protocol requirements to phase out manufacture of all CFC-containing beclometasone products by 2010.

Patients on Beclazone Easi-Breathe will need to be transferred to an alternative device and/or product that suits the patient.

The discontinuation does not affect Qvar Easi-Breathe or Salamol Easi-Breathe.

View Beclazone Easi-Breathe drug record

Further information: Teva

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Trial of interferon beta in COVID-19 patients begins in UK

Trial of interferon beta in COVID-19 patients begins in UK

A global phase III clinical trial to evaluate an inhaled...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New muscle spasm treatment option

New muscle spasm treatment option

Myopridin (pridinol) can be prescribed to treat skeletal...